ALEXANDRIA, Va., Jan. 21 -- Dana-Farber Cancer Institute, Boston, and Genus Oncology, Chicago, have been assigned a patent (9,546,201) developed by two co-inventors for "MUC-1 cytoplasmic domain peptides as inhibitors of cancer." The co-inventors are Donald W. Kufe, Wellesley, Massachusetts, and Surender Kharbanda, Natick, Massachusetts.

The patent application was filed on Feb. 12, 2015 (14/620,349). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Pa . . .